GE HealthCare Technologies (GEHC) Cash & Equivalents (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Cash & Equivalents came in at $2.1 billion in Q2 2026, down 44.03% YoY from $3.8 billion in Q2 2025, and down 7.87% on a QoQ basis from $2.3 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Cash & Equivalents (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Cash & Equivalents data on file, last reported at $2.1 billion in Q2 2026.
- Quarterly Cash & Equivalents fell 44.03% year-over-year to $2.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.1 billion (down 44.03% YoY) and the FY2025 annual result came in at $4.5 billion, up 56.07% from the prior year.
- Cash & Equivalents eased to $2.1 billion in Q2 2026, from $2.3 billion in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $4.5 billion in Q4 2025 to a low of $504.0 million in Q3 2022.
- A 5-year average of $2.4 billion and a median of $2.4 billion in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 380.16% — and 2026, when it slumped 44.03%.
- Tracing GEHC's Cash & Equivalents over 5 years: stood at $1.5 billion in 2022, then surged by 72.71% to $2.5 billion in 2023, then grew by 15.44% to $2.9 billion in 2024, then surged by 56.07% to $4.5 billion in 2025, then plunged by 53.31% to $2.1 billion in 2026.
- The last three Cash & Equivalents figures came in at $2.1 billion (Q2 2026), $2.3 billion (Q1 2026), and $4.5 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.29 Bn |
| Dec 31, 2025 | 4.52 Bn |
| Sep 30, 2025 | 4.03 Bn |
| Jun 30, 2025 | 3.77 Bn |
| Mar 31, 2025 | 2.48 Bn |
| Dec 31, 2024 | 2.89 Bn |
| Sep 30, 2024 | 3.57 Bn |
| Jun 30, 2024 | 2.02 Bn |
| Mar 31, 2024 | 2.57 Bn |
| Dec 31, 2023 | 2.51 Bn |
| Sep 30, 2023 | 2.42 Bn |
| Jun 30, 2023 | 1.95 Bn |
| Mar 31, 2023 | 2.33 Bn |
| Dec 31, 2022 | 1.45 Bn |
| Sep 30, 2022 | 504.00 Mn |
| Jun 30, 2022 | 530.00 Mn |
| Mar 31, 2022 | 506.00 Mn |